Skip to main content

Bay Area biotech boosts IPO targets by 38%, hopes to raise up to $254M

The South San Francisco company is one of five local IPOs waiting in the wings from the life science sector that has already produced six IPOs in the region that have brought returns of between 54% and 188% so far in 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.